Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Identification of non-HLA genes associated with development of islet autoimmunity and type 1 diabetes in the prospective TEDDY cohort.

Journal of autoimmunity | 2018

Traditional linkage analysis and genome-wide association studies have identified HLA and a number of non-HLA genes as genetic factors for islet autoimmunity (IA) and type 1 diabetes (T1D). However, the relative risk associated with previously identified non-HLA genes is usually very small as measured in cases/controls from mixed populations. Genetic associations for IA and T1D may be more accurately assessed in prospective cohorts. In this study, 5806 subjects from the TEDDY (The Environmental Determinants of Diabetes in the Young) study, an international prospective cohort study, were genotyped for 176,586 SNPs on the ImmunoChip. Cox proportional hazards analyses were performed to discover the SNPs associated with the risk for IA, T1D, or both. Three regions were associated with the risk of developing any persistent confirmed islet autoantibody: one known region near SH2B3 (HR = 1.35, p = 3.58 × 10-7) with Bonferroni-corrected significance and another known region near PTPN22 (HR = 1.46, p = 2.17 × 10-6) and one novel region near PPIL2 (HR = 2.47, p = 9.64 × 10-7) with suggestive evidence (p < 10-5). Two known regions (PTPN22: p = 2.25 × 10-6, INS; p = 1.32 × 10-7) and one novel region (PXK/PDHB: p = 8.99 × 10-6) were associated with the risk for multiple islet autoantibodies. First appearing islet autoantibodies differ with respect to association. Two regions (INS: p = 5.67 × 10-6 and TTC34/PRDM16: 6.45 × 10-6) were associated if the fist appearing autoantibody was IAA and one region (RBFOX1: p = 8.02 × 10-6) was associated if the first appearing autoantibody was GADA. The analysis of T1D identified one region already known to be associated with T1D (INS: p = 3.13 × 10-7) and three novel regions (RNASET2, PLEKHA1, and PPIL2; 5.42 × 10-6 > p > 2.31 × 10-6). These results suggest that a number of low frequency variants influence the risk of developing IA and/or T1D and these variants can be identified by large prospective cohort studies using a survival analysis approach.

Pubmed ID: 29310926 RIS Download

Research resources used in this publication

None found

Additional research tools detected in this publication

Antibodies used in this publication

None found

Associated grants

  • Agency: NIDDK NIH HHS, United States
    Id: U01 DK063821
  • Agency: NIDDK NIH HHS, United States
    Id: UC4 DK063863
  • Agency: NIDDK NIH HHS, United States
    Id: U01 DK063861
  • Agency: NCATS NIH HHS, United States
    Id: UL1 TR001427
  • Agency: NIDDK NIH HHS, United States
    Id: U01 DK063790
  • Agency: NCATS NIH HHS, United States
    Id: UL1 TR001082
  • Agency: NIDDK NIH HHS, United States
    Id: P30 DK017047
  • Agency: NCATS NIH HHS, United States
    Id: UL1 TR000064
  • Agency: NLM NIH HHS, United States
    Id: HHSN267200700014C
  • Agency: NIDDK NIH HHS, United States
    Id: U01 DK063836
  • Agency: NIDDK NIH HHS, United States
    Id: U01 DK063829
  • Agency: NIDDK NIH HHS, United States
    Id: U01 DK063865
  • Agency: NIDDK NIH HHS, United States
    Id: UC4 DK095300
  • Agency: NIDDK NIH HHS, United States
    Id: UC4 DK063861
  • Agency: NIDDK NIH HHS, United States
    Id: UC4 DK063829
  • Agency: NIDDK NIH HHS, United States
    Id: UC4 DK063821
  • Agency: NIDDK NIH HHS, United States
    Id: UC4 DK117483
  • Agency: NIDDK NIH HHS, United States
    Id: UC4 DK063836
  • Agency: NIDDK NIH HHS, United States
    Id: UC4 DK112243
  • Agency: NIDDK NIH HHS, United States
    Id: UC4 DK063865
  • Agency: NIDDK NIH HHS, United States
    Id: U01 DK063863
  • Agency: NIDDK NIH HHS, United States
    Id: UC4 DK106955
  • Agency: NIDDK NIH HHS, United States
    Id: UC4 DK100238

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


International HapMap Project (tool)

RRID:SCR_002846

THIS RESOURCE IS NO LONGER IN SERVICE, documented August 22, 2016. A multi-country collaboration among scientists and funding agencies to develop a public resource where genetic similarities and differences in human beings are identified and catalogued. Using this information, researchers will be able to find genes that affect health, disease, and individual responses to medications and environmental factors. All of the information generated by the Project will be released into the public domain. Their goal is to compare the genetic sequences of different individuals to identify chromosomal regions where genetic variants are shared. Public and private organizations in six countries are participating in the International HapMap Project. Data generated by the Project can be downloaded with minimal constraints. HapMap project related data, software, and documentation include: bulk data on genotypes, frequencies, LD data, phasing data, allocated SNPs, recombination rates and hotspots, SNP assays, Perlegen amplicons, raw data, inferred genotypes, and mitochondrial and chrY haplogroups; Generic Genome Browser software; protocols and information on assay design, genotyping and other protocols used in the project; and documentation of samples/individuals and the XML format used in the project.

View all literature mentions